HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 2.490
-0.010 (-0.40%)
Apr 29, 2025, 2:45 PM CST
SHE:002437 Revenue
HARBIN GLORIA PHARMACEUTICALS Co., LTD had revenue of 551.26M CNY in the quarter ending March 31, 2025, a decrease of -7.06%. This brings the company's revenue in the last twelve months to 2.40B, down -5.48% year-over-year. In the year 2024, HARBIN GLORIA PHARMACEUTICALS Co., LTD had annual revenue of 2.44B, down -7.06%.
Revenue (ttm)
2.40B
Revenue Growth
-5.48%
P/S Ratio
2.32
Revenue / Employee
777.59K
Employees
3,085
Market Cap
5.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.44B | -185.31M | -7.06% |
| Dec 31, 2023 | 2.63B | -481.91M | -15.51% |
| Jan 1, 2023 | 3.11B | -37.37M | -1.19% |
| Jan 1, 2022 | 3.15B | 90.36M | 2.96% |
| Dec 31, 2020 | 3.05B | -2.00B | -39.55% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |